Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00574782
NCT00574782
View on ClinicalTrials.gov
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)
Completed
OBSERVATIONAL
Enrollment
2,660
Participants
Timeline
Start Date
September 30, 2003
Conditions
Hypercholesterolemia
Coronary Heart Disease
Peripheral Vascular Disease
CVA
Diabetes
Sponsors
Lead Sponsor
AstraZeneca
All Listed Sponsors
lead
AstraZeneca
INDUSTRY